Portfolio and Case Studies

2024

2023

2021

2021

2021

2020

2019

2019

2019

2018

2018

2016

FDA-Approved Abl/EGFR/PDGFR Kinase Inhibitors Show Potent Efficacy Against Pandemic and Seasonal Influenza A Virus infections of human lung explants

iScience DOI: 10.1016/j.isci.2023.106309

The Raf kinase inhibitors Dabrafenib and Regorafenib impair Zika virus replication via distinct mechanisms

Journal of Virology DOI: 10.1128/jvi.00618-24

Influenza Vaccines: Successes and Continuing ChallengeS

Journal of Infectious Diseases DOI: 10.1093/infdis/jiab269

Aging and Options to Halt Declining Immunity to Virus Infections

Frontiers in Immunology DOI: 10.3389/fimmu.2021.681449

Impaired immune response mediated by Prostaglandin E2 promotes COVID-19 disease

Plos One DOI: 10.1371/journal.pone.0255335

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63

Scientific Reports DOI: 10.1038/s41598-020-78506-9

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination

Journal of Clinical Virology DOI: 10.1016/j.jcv.2019.08.009

Response Modifiers: Tweaking the Immune Response against Influenza Virus

Frontiers in Immunology DOI: 10.3389/fimmu.2019.00809

Influenza Virus Infections and Cellular Kinases

Viruses DOI: 10.3390/v11020171

Broadly protective influenza vaccines: design and production platforms

Current Opinion in Virology DOI: 10.1016/j.coviro.2018.11.005

Complete Genome Sequence of an ON1 Human Respiratory Syncytial Virus Strain Isolated in Lebanon in 2015

Genome Announcement DOI: 10.1128/genomeA.00316-18

Respiratory Mucosal Proteome Quantification in Human Influenza Infections

Plos One DOI: 10.1371/journal.pone.0153674

SELECTED PUBLICATIONS

For a comprehensive list of peer-reviewed publications spanning nearly two decades of research in virology, immunology, and vaccine development,

View Google Scholar Profile